Endogenous nanoplatforms for tumor photoimmunotherapy: Hypoxia modulation and STING pathway activation
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer Research and Treatments · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (68)
Show source-provided references
1. Nanomedicine in cancer therapy10.1038/s41392-023-01536-y ↗
2. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
3. Marriage of black phosphorus and Cu2+ as effective photothermal agents for PET-guided combination cancer therapy10.1038/s41467-020-16513-0 ↗
4. Nanomaterials for theranostics: recent advances and future challenges10.1021/cr300213b ↗
5. Immunological nanomaterials to combat cancer metastasis10.1039/D2CS00968D ↗
6. The updated landscape of tumor microenvironment and drug repurposing10.1038/s41392-020-00280-x ↗
7. Reconstruction of the tumor spatial microenvironment along the malignant-boundary-nonmalignant axis10.1038/s41467-023-36560-7 ↗
8. An ultrasound-driven immune-boosting molecular machine for systemic tumor suppression10.1126/sciadv.abj4796 ↗
9. A cascade nanozyme with amplified sonodynamic therapeutic effects through comodulation of hypoxia and immunosuppression against cancer10.1021/acsnano.1c07504 ↗
10. Manipulation of immune‒vascular crosstalk: new strategies towards cancer treatment10.1016/j.apsb.2020.09.014 ↗
11. Decomposable nanoagonists enable NIR-elicited cGAS-STING activation for Tandem-amplified Photodynamic-metalloimmunotherapy
12. Tumor-permeated bioinspired theranostic nanovehicle remodels tumor immunosuppression for cancer therapy10.1016/j.biomaterials.2020.120609 ↗
13. Overcoming cancer therapy resistance: from drug innovation to therapeutics10.1016/j.drup.2025.101229 ↗
14. Oxygen self-supply engineering-ferritin for the relief of hypoxia in tumors and the enhancement of photodynamic therapy efficacy
15. Harnessing GLUT1-targeted pro-oxidant ascorbate for Synergistic Phototherapeutics10.1002/anie.202110832 ↗
16. The cellular-centered view of hypoxia tumor microenvironment: molecular mechanisms and therapeutic interventions10.1016/j.bbcan.2024.189137 ↗
17. A micro-metabolic rewiring assay for assessing hypoxia-associated cancer metabolic heterogeneity
18. Targeting TRAP1-dependent metabolic reprogramming to overcome doxorubicin resistance in quiescent breast cancer10.1016/j.drup.2025.101226 ↗
19. Hypoxia inducible factor-1α drives cancer resistance to cuproptosis10.1016/j.ccell.2025.02.015 ↗
20. Hypoxia-inducible factors: master regulators of cancer progression10.1016/j.trecan.2016.10.016 ↗
21. Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumors through cGAS-STING pathway activation10.1038/s41467-023-38601-7 ↗
22. Bioorthogonal guided activation of cGAS-STING by AIE photosensitizer nanoparticles for targeted tumor therapy and imaging10.1002/adma.202305668 ↗
23. Recent progress in carrier-free nanomedicine for tumor phototherapy10.1002/adhm.202202307 ↗
24. Bioactivable STING nanoagonists to synergize NIR-II mild photothermal therapy primed robust and long-term anticancer immunity10.1002/adma.202303149 ↗
25. Recent organic photosensitizer designs for evoking proinflammatory regulated cell death in antitumor immunotherapy10.1002/smtd.202201614 ↗
26. Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging10.1002/adma.201301890 ↗
27. Thermal-sensitive lipid nanoparticles potentiate anti-PD therapy through enhancing drug penetration and T lymphocytes infiltration in metastatic tumor10.1016/j.canlet.2021.09.031 ↗
28. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer10.1039/C8CS00618K ↗
29. Deep downregulation of PD-L1 by caged peptide-conjugated AIEgen/miR-140 nanoparticles for enhanced immunotherapy10.1002/anie.202117798 ↗
30. Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumors through cGAS-STING pathway activation10.1038/s41467-023-38601-7 ↗
31. Emerging combination strategies with phototherapy in cancer nanomedicine10.1039/D0CS00215A ↗
32. pH-triggered conformational change of antp-based drug delivery platform for tumor treatment with combined photothermal therapy and chemotherapy10.1002/adhm.201900306 ↗
33. A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice10.1007/s10637-010-9435-1 ↗
34. Inhibitory effects of multivalent polypeptides on the proliferation and metastasis of breast cancer cells10.1021/acsmedchemlett.9b00339 ↗
35. Inhibition by tyroserleutide (YSL) on the invasion and adhesion of the mouse melanoma cell10.2119/2006-00061.Yao ↗
36. Effective antitumor of orally intestinal targeting penetrating peptide-loaded tyroserleutide/PLGA nanoparticles in hepatocellular carcinoma10.2147/IJN.S315713 ↗
37. Tyroserleutide-based gene vector for suppressing VEGF expression in cancer therapy10.1016/j.biomaterials.2012.08.022 ↗
38. Effects of tyroserleutide on phosphatidylinositol 3′-kinase/AKT pathway in human hepatocellular carcinoma cell10.3109/1061186X.2013.844820 ↗
39. Tripeptide tyroserleutide enhances the antitumor effects of macrophages and stimulates macrophage secretion of IL-1beta, TNF-alpha, and NO in vitro10.1007/s00262-005-0024-7 ↗
40. Effect and mechanism of actionin vitroof cyclodextrin derivative nanoparticles loaded with tyroserleutide on hepatoma10.1088/1361-6528/abf3f2 ↗
41. Self-assembling endogenous biliverdin as a versatile near-infrared photothermal nanoagent for cancer theranostics10.1002/adma.201900822 ↗
42. Properties and composition of the bile pigment giving a direct diazo reaction10.1038/178312a0 ↗
43. Recent progress in the development of multifunctional nanoplatform for precise tumor phototherapy
44. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors10.7150/thno.45511 ↗
45. Minimally invasive nanomedicine: nanotechnology in photo-/ultrasound-/radiation-/magnetism-mediated therapy and imaging10.1039/D1CS01148K ↗
46. Functional nanomaterials based on self-assembly of endogenic NIR-absorbing pigments for diagnostic and therapeutic applications10.1002/smtd.202101359 ↗
47. Dual-targeted assembled nanodrugs for near-infrared photothermal immunotherapy of triple-negative breast cancer10.1021/acsami.4c18320 ↗
48. Environmentally responsive hydrogel promotes vascular normalization to enhance STING anti-tumor immunity10.1016/j.jconrel.2024.06.052 ↗
49. Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: a comprehensive review of strategies and future perspectives
50. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy10.1038/s41422-020-00395-4 ↗
51. Tumor microenvironment-activable manganese-boosted catalytic immunotherapy combined with PD-1 checkpoint blockade10.1021/acsnano.2c06646 ↗
52. Manganese-based tumor immunotherapy
53. Biomimetic manganese-based theranostic nanoplatform for cancer multimodal imaging and twofold immunotherapy
54. Mn(2+)/CpG oligodeoxynucleotides codecorated black phosphorus nanosheet platform for enhanced antitumor potency in multimodal therapy10.1021/acsnano.3c07123 ↗
55. NIR/MRI-guided oxygen-independent carrier-free anti-tumor nano-theranostics
56. Biodegradable biliverdin nanoparticles for efficient photoacoustic imaging10.1021/acsnano.9b01201 ↗
57. Dual-modality imaging-guided manganese-based nanotransformer for enhanced gas-Photothermal therapy combined immunotherapeutic strategy against triple-negative breast cancer10.1002/smll.202307961 ↗
58. Reversibly photoswitchable protein assemblies with collagen affinity for in vivo photoacoustic imaging of tumors10.1126/sciadv.adn8274 ↗
59. Monitoring tumour microenvironment changes during anti-angiogenesis therapy using functional MRI10.1007/s10456-019-09670-4 ↗
60. Near-InfraRed PhotoImmunoTherapy (NIR-PIT) for the local control of solid cancers: challenges and potentials for human applications10.1016/j.critrevonc.2021.103325 ↗
61. Nano-econazole enhanced PD-L1 checkpoint blockade for synergistic antitumor immunotherapy against pancreatic ductal adenocarcinoma
62. Multifunctional inorganic nanomaterials for cancer photoimmunotherapy10.1002/cac2.12255 ↗
63. Self-assembling endogenous biliverdin as a versatile near-infrared photothermal nanoagent for cancer theranostics10.1002/adma.201900822 ↗
64. Recent advances in stimuli-responsive platforms for cancer immunotherapy10.1021/acs.accounts.0c00334 ↗
65. Herpesvirus-mimicking DNAzyme-loaded nanoparticles as a mitochondrial DNA stress inducer to activate innate immunity for tumor therapy10.1002/adma.202204585 ↗
66. Tyroserleutide-based gene vector for suppressing VEGF expression in cancer therapy10.1016/j.biomaterials.2012.08.022 ↗
67. Multifunctional nanoassembly for MRI-trackable dendritic cell dependent and independent photoimmunotherapy10.1021/acs.nanolett.3c03098 ↗
68. A hypoxia-activated and microenvironment-remodeling nanoplatform for multifunctional imaging and potentiated immunotherapy of cancer10.1038/s41467-024-53906-x ↗